-
My Account
In App
My Account
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 1 | 1582.30 | 1638.00 | 54 |
| 30 | 1580.00 | 1640.00 | 50 |
| 59 | 1579.30 | 1749.90 | 25 |
| 1 | 1578.50 | 1775.00 | 1 |
| 1 | 1577.95 | 1849.00 | 1 |
| 0 | Total | Total | 0 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 1 | 1582.30 | 1638.00 | 54 |
| 30 | 1580.00 | 1640.00 | 50 |
| 59 | 1579.30 | 1749.90 | 25 |
| 1 | 1578.50 | 1775.00 | 1 |
| 1 | 1577.95 | 1849.00 | 1 |
| 0 | Total | Total | 0 |
| Open | 1,627.70 |
| Previous Close | 1,619.90 |
| Volume | 40,393.00 |
| Value (Lacs) | 642.94 |
| VWAP | 1,599.94 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 21,681 |
| High | 1,628.30 |
| Low | 1,582.20 |
| UC Limit | 1,943.80 |
| LC Limit | 1,296.00 |
| 52 Week High | 1,910.00 |
| 52 Week Low | 1,097.20 |
| Face Value | 1.00 |
| All Time High | 1,910.00 |
| All Time Low | 321.00 |
| 20D Avg Volume | 273,978 |
| 20D Avg Delivery(%) | 27.66 |
| Book Value Per Share | 203.47 |
| Dividend Yield | 0.46 |
| TTM EPS See historical trend | 28.41 (+10.96% YoY) |
| TTM PE See historical trend | 56.03 (Average PE) |
| P/B See historical trend | 7.83 (High P/B) |
| Sector PE | 39.72 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
5 out of 9 years Eris Lifesciences has given negative returns in October.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| October | 7.95% (2021) | 3.35% | -6.95% (2020) | -4.07% | -0.77% |
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y Aug 12 2025 01:06 PM
Eris Lifesciences to meet investors in Singapore and Hong Kong Aug 11 2025 05:27 PM
Neutral Eris Lifesciences; target of Rs 1700: Motilal Oswal Aug 08 2025 01:03 PM
Eris Lifesciences eyes Novo Nordisku2019s exit to expand human insulin play in India Aug 07 2025 09:31 PM
Posted by : The Fixed Income
Repost this message
Build Steady Wealth with a Secured NBFC Bond Investment VIVRITI CAPITAL LIMITED 2027 ✔️ Coupon: 9.15% ✔️ Rating: CARE A+ Stable ✔️ Tenor: 2y (Maturity: 04/Nov/2027) Senior Secured Bond | NBFC Bond | High Return Bond | Listed This bond offers investors the opportunity to earn steady returns while maintaining a conservative risk profile. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJhbmJ3PT0=/915-vivriti-capital-limited-2027?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 2079000 | Price 1350.18 | % Traded 1.55 |
| Qty 2000000 | Price 1350 | % Traded 1.49 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Eris Life | 1,591.70 | -1.74 | 21,681.11 | 56.03 | 7.82 | 12.32 | 20.30 | 374 | 2,893 | 0.85 |
| Sun Pharma | 1,690.70 | -0.75 | 405,655.56 | 39.11 | 5.62 | 15.13 | -8.56 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,738.00 | 1.25 | 178,872.73 | 77.56 | 11.95 | 14.63 | 14.40 | 2,191 | 9,360 | 0.00 |
| Cipla | 1,501.30 | -2.52 | 121,270.69 | 22.49 | 4.28 | 16.90 | -3.25 | 5,291 | 27,547 | 0.00 |
| Torrent Pharma | 3,560.10 | -1.17 | 120,489.96 | 60.19 | 16.06 | 25.17 | 11.16 | 1,911 | 11,516 | 0.40 |
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
